China National Medicines Corporation Ltd.
600511
Kedudukan dalam Saham
#4955
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Harga Saham
$3.90
Modal Pasaran
$2.94B
Perubahan (1 hari)
-1.46%
Perubahan (1 tahun)
-3.02%
Negara
CN
Perdagangan China National Medicines Corporation Ltd. (600511)
Kategori
Healthcare
Nisbah P/E bagi China National Medicines Corporation Ltd. (600511)
Nisbah P/E pada October 2026 TTM: 10.61
Menurut laporan kewangan dan harga saham terkini China National Medicines Corporation Ltd., nisbah P/E semasa (TTM) ialah 10.61. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 10.19.
Sejarah nisbah P/E bagi China National Medicines Corporation Ltd. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 10.61 | -17.79% |
| 2024 | 12.91 | 26.69% |
| 2023 | 10.19 | -4.93% |
| 2022 | 10.72 | -20.97% |
| 2021 | 13.56 | -49.60% |
| 2020 | 26.91 | 107.55% |
| 2019 | 12.96 | 6.47% |
| 2018 | 12.18 | -32.89% |
| 2017 | 18.14 | -52.39% |
| 2016 | 38.11 | 7.58% |
| 2015 | 35.42 | 15.14% |
| 2014 | 30.76 | 40.20% |
| 2013 | 21.94 | 5.56% |
| 2012 | 20.79 | -1.87% |
| 2011 | 21.18 | -44.69% |
| 2010 | 38.30 | -29.19% |
| 2009 | 54.09 | 53.22% |
| 2008 | 35.30 | -43.44% |
| 2007 | 62.42 | 127.88% |
| 2006 | 27.39 | 115.03% |
| 2005 | 12.74 | -30.45% |
| 2004 | 18.32 | -28.44% |
| 2003 | 25.59 | -40.19% |
| 2002 | 42.79 | -28.15% |
| 2001 | 59.56 | -29.55% |
| 2000 | 84.55 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 26.02 | 145.17% |
US
|
|
| - | - |
US
|
|
| 34.08 | 221.08% |
US
|
|
| - | - |
US
|
|
| 45.62 | 329.81% |
AU
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.